Tag: Antibody

Severe COVID-19 Disrupts Gut Health: Study
Severe COVID-19 Disrupts Gut Health: Study

The researchers noted that while severe COVID-19 can lead to breathing problems and high fever, some patients can experience diarrhea, nausea and vomiting, which suggests involvement of the gastrointestinal tract.

  • Monday, 21 February 2022
Breakthrough COVID-19 Infections Generate Strong Antibody Response: Study
Breakthrough COVID-19 Infections Generate Strong Antibody Response: Study

The team found that people who had received three-vaccine doses, those vaccinated after recovering from COVID-19, and those with a breakthrough infection had almost comparable neutralising antibody responses, in terms of magnitude and breadth.

  • Monday, 24 January 2022
Covid19
ICMR Study On COVID19 Antibodies Shows Variable Patterns: Odisha Health Services Director

The study conducted by Indian Council of Medical Research (ICMR) on COVID antibody reveals that sero prevalence may vary from state to state.

Video Icon
  • Thursday, 22 July 2021
antibody
Antibody that can help kill cancer cells emerges

New York: Researchers have found that an antibody — originally developed for studying the autoimmune condition multiple sclerosis — can promote the immune system’s ability to fight cancer and decreases tumour growth. In a study published in the journal Science Immunology, the researchers reported that the antibody decreased tumour growth in models of melanoma (skin […]

  • Monday, 05 July 2021
COVID-19-testing
India received 5 lakh rapid COVID-19 testing kits from China: Health Ministry

New Delhi: India has received the much-awaited five lakh rapid COVID-19 testing kits from China and these are not meant for early diagnosis of the disease rather for monitoring whether coronavirus hotspots in India are increasing or showing a declining trend, the government said on Thursday. Addressing a daily briefing on COVID-19 situation in the […]

  • Saturday, 17 April 2021
Coronavirus-5
Antibody Found To Block COVID-19 Virus 100% In Experiments

San Francisco: US-based Sorrento Therapeutics has announced that an antibody has demonstrated its ability to completely block SARS-CoV-2 infection of healthy cells in preclinical laboratory experiments. SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The results on Friday showed that Sorrento’s anti-SARS-CoV-2 antibody, STI-1499, completely neutralised the virus infectivity at a very low antibody […]

  • Friday, 16 April 2021
scrollToTop